{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:52:39Z","timestamp":1761918759993},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1038\/ncpuro0323","type":"journal-article","created":{"date-parts":[[2005,10,14]],"date-time":"2005-10-14T10:30:32Z","timestamp":1129285832000},"page":"492-501","source":"Crossref","is-referenced-by-count":59,"title":["Therapy Insight: bladder dysfunction associated with multiple sclerosis"],"prefix":"10.1038","volume":"2","author":[{"given":"Vinay","family":"Kalsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare J","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpuro0323_CR1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0022-5347(01)61760-9","volume":"161","author":"SE Litwiller","year":"1999","unstructured":"Litwiller SE et al. (1999) Multiple sclerosis and the urologist. J Urol 161: 743\u2013757","journal-title":"J Urol"},{"key":"BFncpuro0323_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/jnnp.56.3.245","volume":"56","author":"CD Betts","year":"1993","unstructured":"Betts CD et al. (1993) Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 56: 245\u2013250","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpuro0323_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11940-001-0002-0","volume":"3","author":"EM Hawker KS and Frohman","year":"2001","unstructured":"Hawker KS and Frohman EM (2001) Bladder, Bowel, and Sexual Dysfunction in Multiple Sclerosis. Curr Treat Options Neurol 3: 207\u2013214","journal-title":"Curr Treat Options Neurol"},{"key":"BFncpuro0323_CR4","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/bmj.1.5445.1265","volume":"5445","author":"H Miller","year":"1965","unstructured":"Miller H et al. (1965) Bladder Dysfunction in Multiple Sclerosis. Br Med J 5445: 1265\u20131269","journal-title":"Br Med J"},{"key":"BFncpuro0323_CR5","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1212\/WNL.43.12.2632","volume":"43","author":"DJ Kidd","year":"1993","unstructured":"Kidd DJ et al. (1993) Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43: 2632\u20132637","journal-title":"Neurology"},{"key":"BFncpuro0323_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000067107","volume":"22","author":"R Zivadinov","year":"2003","unstructured":"Zivadinov R et al. (2003) The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology 22: 65\u201374","journal-title":"Neuroepidemiology"},{"key":"BFncpuro0323_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0022-5347(01)67258-6","volume":"154","author":"EL Koldewijn","year":"1995","unstructured":"Koldewijn EL et al. (1995) Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J Urol 154: 169\u2013173","journal-title":"J Urol"},{"key":"BFncpuro0323_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/135245850100700404","volume":"7","author":"MW Nortvedt","year":"2001","unstructured":"Nortvedt MW et al. (2001) Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Mult Scler 7: 231\u2013235","journal-title":"Mult Scler"},{"key":"BFncpuro0323_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/PL00007835","volume":"249","author":"O Fernandez","year":"2002","unstructured":"Fernandez O (2002) Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis J Neurol 249: 1\u20138","journal-title":"J Neurol"},{"key":"BFncpuro0323_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/brain\/124.2.369","volume":"124","author":"BS Athwal","year":"2001","unstructured":"Athwal BS et al. (2001) Brain responses to changes in bladder volume and urge to void in healthy men. Brain 124: 369\u2013377","journal-title":"Brain"},{"key":"BFncpuro0323_CR11","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/S0022-5347(05)64290-5","volume":"168","author":"S Matsuura","year":"2002","unstructured":"Matsuura S et al. (2002) Human brain region response to distention or cold stimulation of the bladder: a positron emission tomography study. J Urol 168: 2035\u20132039","journal-title":"J Urol"},{"key":"BFncpuro0323_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/brain\/120.1.111","volume":"120","author":"BF Blok","year":"1997","unstructured":"Blok BF et al. (1997) A PET study on brain control of micturition in humans. Brain 120: 111\u2013121","journal-title":"Brain"},{"key":"BFncpuro0323_CR13","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1093\/brain\/121.11.2033","volume":"121","author":"BF Blok","year":"1998","unstructured":"Blok BF et al. (1998) Brain activation during micturition in women. Brain 121: 2033\u20132042","journal-title":"Brain"},{"issue":"Suppl 1","key":"BFncpuro0323_CR14","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/S0090-4295(01)01633-8","volume":"59","author":"BF Blok","year":"2002","unstructured":"Blok BF (2002) Central pathways controlling micturition and urinary continence. Urology 59 (Suppl 1): S13\u2013S17","journal-title":"Urology"},{"key":"BFncpuro0323_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0022-5347(17)50216-5","volume":"131","author":"JG Blaivas","year":"1984","unstructured":"Blaivas JG and Barbalias GA (1984) Detrusor-external sphincter dyssynergia in men with multiple sclerosis: an ominous urologic condition. J Urol 131: 91\u201394","journal-title":"J Urol"},{"issue":"Suppl","key":"BFncpuro0323_CR16","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/0165-1838(90)90105-R","volume":"30","author":"WC de Groat","year":"1990","unstructured":"de Groat WC et al. (1990) Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 30 (Suppl): S71\u2013S77","journal-title":"J Auton Nerv Syst"},{"key":"BFncpuro0323_CR17","first-page":"F226","volume":"275","author":"L Birder","year":"1998","unstructured":"Birder L et al. (1998) Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol 275: F226\u2013F229","journal-title":"Am J Physiol"},{"key":"BFncpuro0323_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/PL00007101","volume":"19","author":"KE Andersson","year":"2001","unstructured":"Andersson KE (2001) The basis for drug treatment of the overactive bladder. World J Urol 19: 294\u2013298","journal-title":"World J Urol"},{"key":"BFncpuro0323_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","volume":"61","author":"PL Abrams","year":"2003","unstructured":"Abrams PL et al. (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61: 37\u201349","journal-title":"Urology"},{"key":"BFncpuro0323_CR20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S0022-5347(17)51716-4","volume":"130","author":"JS Wheeler Jr","year":"1983","unstructured":"Wheeler JS Jr et al. (1983) The changing neurourologic pattern of multiple sclerosis. J Urol 130: 1123\u20131126","journal-title":"J Urol"},{"key":"BFncpuro0323_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0090-4295(00)01070-0","volume":"57","author":"SJ Ciancio","year":"2001","unstructured":"Ciancio SJ et al. (2001) Urodynamic pattern changes in multiple sclerosis. Urology 57: 239\u2013245","journal-title":"Urology"},{"key":"BFncpuro0323_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0022-5347(17)49710-2","volume":"132","author":"SA Awad","year":"1984","unstructured":"Awad SA et al. (1984) Relationship between neurological and urological status in patients with multiple sclerosis. J Urol 132: 499\u2013502","journal-title":"J Urol"},{"key":"BFncpuro0323_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/brain\/121.4.687","volume":"121","author":"A Lycklama","year":"1998","unstructured":"Lycklama A et al. (1998) Brain and Spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 121: 687\u2013697","journal-title":"Brain"},{"key":"BFncpuro0323_CR24","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/S0022-5347(01)63791-1","volume":"159","author":"Y Kim","year":"1998","unstructured":"Kim Y et al. (1998) The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis. J Urol 159: 972\u2013976","journal-title":"J Urol"},{"key":"BFncpuro0323_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1034\/j.1600-0404.2003.00184.x","volume":"109","author":"M Ukkonen","year":"2004","unstructured":"Ukkonen M et al. (2004) Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system. Acta Neurol Scand 109: 100\u2013105","journal-title":"Acta Neurol Scand"},{"key":"BFncpuro0323_CR26","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0022-5347(17)35131-5","volume":"151","author":"LT Sirls","year":"1994","unstructured":"Sirls LT et al. (1994) Role of limited evaluation and aggressive medical management in multiple sclerosis: a review of 113 patients. J Urol 151: 946\u2013950","journal-title":"J Urol"},{"key":"BFncpuro0323_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1046\/j.1365-2680.2001.00231.x","volume":"21","author":"R Chess-Williams","year":"2001","unstructured":"Chess-Williams R et al. (2001) The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro. J Auton Pharmacol 21: 243\u2013248","journal-title":"J Auton Pharmacol"},{"key":"BFncpuro0323_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0090-4295(02)01819-8","volume":"60","author":"S Sigala","year":"2002","unstructured":"Sigala S et al. (2002) Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. Urology 60: 719\u2013725","journal-title":"Urology"},{"key":"BFncpuro0323_CR29","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0022-5347(01)67039-3","volume":"154","author":"DR Harriss","year":"1995","unstructured":"Harriss DR et al. (1995) Expression of muscarinic M3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells. J Urol 154: 1241\u20131245","journal-title":"J Urol"},{"key":"BFncpuro0323_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/00002512-200118040-00005","volume":"18","author":"D Clemett","year":"2001","unstructured":"Clemett D and Jarvis B (2001) Tolterodine: a review of its use in the treatment of overactive bladder. Drugs Aging 18: 277\u2013304","journal-title":"Drugs Aging"},{"key":"BFncpuro0323_CR31","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/00912700122010528","volume":"41","author":"A Todorova","year":"2001","unstructured":"Todorova A et al. (2001) Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol 41: 636\u2013644","journal-title":"J Clin Pharmacol"},{"key":"BFncpuro0323_CR32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000117359","volume":"30","author":"HH Kornhuber","year":"1990","unstructured":"Kornhuber HH and Schutz A (1990) Efficient treatment of neurogenic bladder disorders in multiple sclerosis with initial intermittent catheterization and ultrasound-controlled training. Eur Neurol 30: 260\u2013267","journal-title":"Eur Neurol"},{"key":"BFncpuro0323_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jnnp.60.1.6","volume":"60","author":"CJ Fowler","year":"1996","unstructured":"Fowler CJ (1996) Investigation of the neurogenic bladder. J Neurol Neurosurg Psychiatry 60: 6\u201313","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpuro0323_CR34","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/jnnp.55.11.986","volume":"55","author":"CJ Fowler","year":"1992","unstructured":"Fowler CJ et al. (1992) Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis). J Neurol Neurosurg Psychiatry 55: 986\u2013989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpuro0323_CR35","volume-title":"Urinary dysfunction and Multiple Sclerosis. Evidence-Based Management Strategies for Urinary Dysfunction in Multiple Sclerosis. Multiple Sclerosis Council for Clinical Practice Guidelines","author":"PT Seland","year":"1999","unstructured":"Seland PT et al. (1999) Urinary dysfunction and Multiple Sclerosis. Evidence-Based Management Strategies for Urinary Dysfunction in Multiple Sclerosis. Multiple Sclerosis Council for Clinical Practice Guidelines. Washington DC: PVA Publications"},{"key":"BFncpuro0323_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0022-5347(17)37727-3","volume":"146","author":"SA Kaplan","year":"1991","unstructured":"Kaplan SA et al. (1991) Bladder and sphincter behavior in patients with spinal cord lesions. J Urol 146: 113\u2013117","journal-title":"J Urol"},{"key":"BFncpuro0323_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0022-5347(01)63048-9","volume":"160","author":"GA Barbalias","year":"1998","unstructured":"Barbalias GA et al. (1998) Vesicourethral dysfunction associated with multiple sclerosis: clinical and urodynamic perspectives. J Urol 160: 106\u2013111","journal-title":"J Urol"},{"issue":"Suppl 2","key":"BFncpuro0323_CR38","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1111\/j.1600-0773.1978.tb03216.x","volume":"43","author":"L Norlen","year":"1978","unstructured":"Norlen L and Sundin T (1978) Alpha-adrenolytic treatment in patients with autonomous bladders. Acta Pharmacol Toxicol (Copenh) 43 (Suppl 2): S31\u2013S34","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"BFncpuro0323_CR39","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/S0022-5347(01)67524-4","volume":"153","author":"JI O'Riordan","year":"1995","unstructured":"O'Riordan JI et al. (1995) Do alpha-blockers have a role in lower urinary tract dysfunction in multiple sclerosis? J Urol 153: 1114\u20131116","journal-title":"J Urol"},{"issue":"Suppl 2","key":"BFncpuro0323_CR40","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1046\/j.1464-410X.2000.00098.x","volume":"86","author":"DA Schwinn","year":"2000","unstructured":"Schwinn DA (2000) Novel role for alpha1-adrenergic receptor subtypes in lower urinary tract symptoms. BJU Int 86 (Suppl 2): S11\u2013S20","journal-title":"BJU Int"},{"key":"BFncpuro0323_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0140-6736(77)91191-6","volume":"1","author":"P Nathan","year":"1977","unstructured":"Nathan P (1977) Emptying the paralysed bladder. Lancet 1: 377","journal-title":"Lancet"},{"key":"BFncpuro0323_CR42","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1046\/j.1464-410X.1997.00227.x","volume":"80","author":"P Dasgupta","year":"1997","unstructured":"Dasgupta P et al. (1997) The 'Queen Square bladder stimulator': a device for assisting emptying of the neurogenic bladder. Br J Urol 80: 234\u2013237","journal-title":"Br J Urol"},{"key":"BFncpuro0323_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1191\/0269215503cr583oa","volume":"17","author":"RS Prasad","year":"2003","unstructured":"Prasad RS et al. (2003) Lower abdominal pressure versus external bladder stimulation to aid bladder emptying in multiple sclerosis: a randomized controlled study. Clin Rehabil 17: 42\u201347","journal-title":"Clin Rehabil"},{"key":"BFncpuro0323_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1464-410X.1989.tb05215.x","volume":"63","author":"DA Rew","year":"1989","unstructured":"Rew DA and Rundle JS (1989) Assessment of the safety of regular DDAVP therapy in primary nocturnal enuresis. Br J Urol 63: 352\u2013353","journal-title":"Br J Urol"},{"key":"BFncpuro0323_CR45","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/jnnp.46.9.854","volume":"46","author":"P Hilton","year":"1983","unstructured":"Hilton P et al. (1983) The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psychiatry 46: 854\u2013855","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpuro0323_CR46","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/jnnp.65.5.778","volume":"65","author":"PA Hoverd","year":"1998","unstructured":"Hoverd PA and Fowler CJ (1998) Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 65: 778\u2013780","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpuro0323_CR47","first-page":"416","volume":"5","author":"N Tubridy","year":"1999","unstructured":"Tubridy N et al. (1999) Long term use of desmopressin for urinary symptoms in multiple sclerosis. Mult Scler 5: 416\u2013417","journal-title":"Mult Scler"},{"key":"BFncpuro0323_CR48","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1464-410X.2005.05337.x","volume":"95","author":"NM Gades","year":"2005","unstructured":"Gades NM et al. (2005) Prevelence of conditions potentially associated with lower urinary tract symptoms in men. BJU Int 95: 554\u2013593","journal-title":"BJU Int"},{"key":"BFncpuro0323_CR49","doi-asserted-by":"crossref","unstructured":"AUA Practice Guidelines Committee (2003) AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 170: 530\u2013547","DOI":"10.1097\/01.ju.0000078083.38675.79"},{"key":"BFncpuro0323_CR50","unstructured":"House of Lords Committee on Science and Technology (1998) House of Lords Committee on Science and Technology. Cannabis: the scientific and medical evidence (9th report). London: Stationary Office"},{"key":"BFncpuro0323_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1191\/1352458504ms1063oa","volume":"10","author":"CM Brady","year":"2004","unstructured":"Brady CM et al. (2004) An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Mult Scler 10: 425\u2013433","journal-title":"Mult Scler"},{"key":"BFncpuro0323_CR52","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","volume":"362","author":"J Zajicek","year":"2003","unstructured":"Zajicek J et al. (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 362: 1517\u20131526","journal-title":"Lancet"},{"key":"BFncpuro0323_CR53","first-page":"607","volume":"23","author":"R Freeman","year":"2004","unstructured":"Freeman R et al. (2004) The effect of cannabinoids on lower urinary tract symptoms in multiple sclerosis: a randomised placebo controlled trial (CAMS-LUTS study). Neurourol Urodyn 23: 607 (A149)","journal-title":"Neurourol Urodyn"},{"key":"BFncpuro0323_CR54","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/0140-6736(92)91186-C","volume":"339","author":"CJ Fowler","year":"1992","unstructured":"Fowler CJ et al. (1992) Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 339: 1239","journal-title":"Lancet"},{"key":"BFncpuro0323_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000020004","volume":"36","author":"M de Seze","year":"1999","unstructured":"de Seze M et al. (1999) Intravesical instillation of capsaicin in urology: A review of the literature. Eur Urol 36: 267\u2013277","journal-title":"Eur Urol"},{"key":"BFncpuro0323_CR56","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0024-3205(96)00567-X","volume":"60","author":"G Appendino","year":"1997","unstructured":"Appendino G and Szallasi A (1997) Euphorbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine. Life Sci 60: 681\u2013696","journal-title":"Life Sci"},{"key":"BFncpuro0323_CR57","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/S0022-5347(05)65183-X","volume":"167","author":"A Giannantoni","year":"2002","unstructured":"Giannantoni A et al. (2002) Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol 167: 1710\u20131714","journal-title":"J Urol"},{"issue":"Suppl 1","key":"BFncpuro0323_CR58","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/S0090-4295(01)01638-7","volume":"59","author":"F Cruz","year":"2002","unstructured":"Cruz F (2002) Vanilloid receptor and detrusor instability. Urology 59 (Suppl 1): S51\u2013S60","journal-title":"Urology"},{"key":"BFncpuro0323_CR59","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1464-410X.2003.04722.x","volume":"93","author":"CM Brady","year":"2004","unstructured":"Brady CM et al. (2004) Parallel changes in bladder suburothelial vanilloid receptor TRPV1 (VR1) and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity (NDO) following intravesical resiniferatoxin treatment. BJU Int 93: 770\u2013776","journal-title":"BJU Int"},{"key":"BFncpuro0323_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/01.ju.0000100385.93801.d4","volume":"171","author":"M de Seze","year":"2004","unstructured":"de Seze M et al. (2004) Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study. J Urol 171: 251\u2013255","journal-title":"J Urol"},{"key":"BFncpuro0323_CR61","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B et al. (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164: 692\u2013697","journal-title":"J Urol"},{"key":"BFncpuro0323_CR62","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A Reitz","year":"2004","unstructured":"Reitz A et al. (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45: 510\u2013515","journal-title":"Eur Urol"},{"key":"BFncpuro0323_CR63","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","volume":"174","author":"A Apostolidis","year":"2005","unstructured":"Apostolidis A et al. (2005) Decreased sensory receptors P2x3 and TRPV1 in suburothealial nerve fibres following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174: 977\u2013983","journal-title":"J Urol"},{"key":"BFncpuro0323_CR64","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","volume":"174","author":"R Popat","year":"2005","unstructured":"Popat R et al. (2005) A comparison between the response of patients with idiopathic detrusor overactivity (IDO) and neurogenic detrusor overactivity (NDO) to the first intradetrusor injection of botulinum A toxin. J Urol 174: 984\u2013988","journal-title":"J Urol"},{"key":"BFncpuro0323_CR65","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1464-410X.2003.04312.x","volume":"92","author":"M Harper","year":"2003","unstructured":"Harper M et al. (2003) A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJU Int 92: 325\u2013326","journal-title":"BJU Int"},{"key":"BFncpuro0323_CR66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1569-9056(05)80414-2","volume":"4","author":"V Kalsi","year":"2005","unstructured":"Kalsi V et al. (2005) A cost consequence model for botulinum toxin-a used in the treatment of 89 patients with detrusor overactivity: preliminary results. Eur Urol 4: 104","journal-title":"Eur Urol"},{"key":"BFncpuro0323_CR67","first-page":"15","volume":"7","author":"JG Chancellor MB and Blaivas","year":"1993","unstructured":"Chancellor MB and Blaivas JG (1993) Multiple Sclerosis. Probl Urol 7: 15\u201333","journal-title":"Probl Urol"},{"key":"BFncpuro0323_CR68","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0022-5347(17)45589-3","volume":"135","author":"B Goldwasser","year":"1986","unstructured":"Goldwasser B and Webster GD (1986) Augmentation and substitution enterocystoplasty. J Urol 135: 215\u2013224","journal-title":"J Urol"},{"key":"BFncpuro0323_CR69","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/S0022-5347(17)38086-2","volume":"146","author":"R Luangkhot","year":"1991","unstructured":"Luangkhot R et al. (1991) Ileocecocystoplasty for the management of refractory neurogenic bladder: surgical technique and urodynamic findings. J Urol 146: 1340\u20131344","journal-title":"J Urol"},{"key":"BFncpuro0323_CR70","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/S0022-5347(05)67010-3","volume":"164","author":"EJ Chartier-Kastler","year":"2000","unstructured":"Chartier-Kastler EJ et al. (2000) Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol 164: 1476\u20131480","journal-title":"J Urol"},{"key":"BFncpuro0323_CR71","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1464-410X.1993.tb00681.x","volume":"72","author":"DG Barnes","year":"1993","unstructured":"Barnes DG et al. (1993) Management of the neuropathic bladder by suprapubic catheterisation. Br J Urol 72: 169\u2013172","journal-title":"Br J Urol"}],"container-title":["Nature Clinical Practice Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0323","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0323.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T23:52:11Z","timestamp":1706658731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpuro0323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["BFncpuro0323"],"URL":"https:\/\/doi.org\/10.1038\/ncpuro0323","relation":{},"ISSN":["1743-4270","1743-4289"],"issn-type":[{"value":"1743-4270","type":"print"},{"value":"1743-4289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}